Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts
Here’s Where To Start if You’re Selling and Buying at the
Same Time
Biggerpockets Pro Members Can Now Turn Home Equity Into a
Flexible Line of Credit With Aven
Deal Diary: How a Math Teacher Bought 19 Doors
NJ developer sues Bravo Capital over stalled HUD refi on
$100M Newark tower
Puck Building condo sells for $42M in off-market
deal
“Black-ish” creator Kenya Barris lists Beverly Hills estate
for $21M three years after buying
Bondholders in danger of losing more than $80M on
A&E debt
What It Really Costs to Live in Millie Bobby Brown’s
Neighborhood
Manhattan luxury contracts buck late summer slump
Manhattan office availability shrinks to six-year
low
